OOIR: Observatory of International Research

Papers

(The H4-Index of Cancer Medicine is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years	92
Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma	88
Enhancement of tumor lethality of ROS in photodynamic therapy	80
Disparities in telemedicine during COVID‐19	77
Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019	76
Role of tumor microenvironment in cancer progression and therapeutic strategy	73
Prehabilitation exercise therapy for cancer: A systematic review and meta‐analysis	73
Artificial intelligence in oncology: Path to implementation	72
Symptom clusters experienced by breast cancer patients at various treatment stages: A systematic review	72
Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe	69
Chinese and global burdens of gastric cancer from 1990 to 2019	66
Safety and Efficacy of PD‐1/PD‐L1 inhibitors combined with radiotherapy in patients with non‐small‐cell lung cancer: a systematic review and meta‐analysis	62
Protein disulphide isomerase inhibition as a potential cancer therapeutic strategy	61
The prognostic utility of pre‐treatment neutrophil‐to‐lymphocyte‐ratio (NLR) in colorectal cancer: A systematic review and meta‐analysis	57
Relationship of established risk factors with breast cancer subtypes	55
Relmacabtagene autoleucel (relma‐cel) CD19 CAR‐T therapy for adults with heavily pretreated relapsed/refractory large B‐cell lymphoma in China	53
Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019	52
Integration of comprehensive genomic profiling, tumor mutational burden, and PD‐L1 expression to identify novel biomarkers of immunotherapy in non‐small cell lung cancer	49
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double‐blind randomized phase 2 trial	44
Breastfeeding reduces the risk of breast cancer: A call for action in high‐income countries with low rates of breastfeeding	44
The effect of anticancer treatment on cancer patients with COVID‐19: A systematic review and meta‐analysis	44
Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015	43
Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017	42
Perspectives and controversies regarding the use of natural products for the treatment of lung cancer	42
Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma	42

Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer	41
Examining the association among fear of COVID‐19, psychological distress, and delays in cancer care	40
Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck cancer	39
Gut microbiota and risk of five common cancers: A univariable and multivariable Mendelian randomization study	38
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients	38
Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study	38
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer	38
The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study	37
A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort	37
The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels	37
Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan	37
Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors	37